The power of this concept was demonstrated when cancer cell membrane-associated cathepsin B was targeted by liposomes with a selective cathepsin B inhibitor as a targeting moiety, and the system demonstrated improved selectivity and targeting efficiency [203]. Here, CTSB is linked to cancer.